Cargando…

Infectious diseases specialist consultation in Staphylococcus lugdunensis bacteremia

BACKGROUND: Commensal coagulase negative Staphylococcus lugdunensis may cause severe bacteremia (SLB) and complications. Treatment of SLB is not fully established and we wanted to evaluate if infectious diseases specialist consultation (IDSC) would improve management and prognosis. METHODS: Multicen...

Descripción completa

Detalles Bibliográficos
Autores principales: Forsblom, Erik, Högnäs, Emma, Syrjänen, Jaana, Järvinen, Asko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509883/
https://www.ncbi.nlm.nih.gov/pubmed/34637480
http://dx.doi.org/10.1371/journal.pone.0258511
_version_ 1784582452168097792
author Forsblom, Erik
Högnäs, Emma
Syrjänen, Jaana
Järvinen, Asko
author_facet Forsblom, Erik
Högnäs, Emma
Syrjänen, Jaana
Järvinen, Asko
author_sort Forsblom, Erik
collection PubMed
description BACKGROUND: Commensal coagulase negative Staphylococcus lugdunensis may cause severe bacteremia (SLB) and complications. Treatment of SLB is not fully established and we wanted to evaluate if infectious diseases specialist consultation (IDSC) would improve management and prognosis. METHODS: Multicenter retrospective study of SLB patients followed for 1 year. Patients were stratified according to bedside (formal), telephone (informal) or lack of IDSC within 7 days of SLB diagnosis. RESULTS: Altogether, 104 SLB patients were identified: 24% received formal bedside and 52% informal telephone IDSC whereas 24% were managed without any IDSC. No differences in demographics, underlying conditions or severity of illness were observed between the groups. Patients with bedside IDSC, compared to telephone IDSC or lack of IDSC, had transthoracic echocardiography more often performed (odds ratio [OR] 4.00; 95% confidence interval [CI] 1.31–12.2; p = 0.012) and (OR 16.0; 95% CI, 4.00–63.9; P<0.001). Bedside IDSC was associated with more deep infections diagnosed compared to telephone IDSC (OR, 7.44; 95% CI, 2.58–21.4; p<0.001) or lack of IDSC (OR, 9.56; 95% CI, 2.43–37.7; p = 0.001). The overall mortality was 7%, 10% and 17% at 28 days, 90 days and 1 year, respectively. Considering all prognostic parameters, patients with IDSC, compared to lack of IDSC, had lower 90 days and 1 year mortality (OR, 0.11; 95% CI, 0.02–0.51; p = 0.005) and (OR, 0.22; 95% CI, 0.07–0.67; p = 0.007). CONCLUSION: IDSC may improve management and outcome of Staphylococcus lugdunensis bacteremia.
format Online
Article
Text
id pubmed-8509883
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-85098832021-10-13 Infectious diseases specialist consultation in Staphylococcus lugdunensis bacteremia Forsblom, Erik Högnäs, Emma Syrjänen, Jaana Järvinen, Asko PLoS One Research Article BACKGROUND: Commensal coagulase negative Staphylococcus lugdunensis may cause severe bacteremia (SLB) and complications. Treatment of SLB is not fully established and we wanted to evaluate if infectious diseases specialist consultation (IDSC) would improve management and prognosis. METHODS: Multicenter retrospective study of SLB patients followed for 1 year. Patients were stratified according to bedside (formal), telephone (informal) or lack of IDSC within 7 days of SLB diagnosis. RESULTS: Altogether, 104 SLB patients were identified: 24% received formal bedside and 52% informal telephone IDSC whereas 24% were managed without any IDSC. No differences in demographics, underlying conditions or severity of illness were observed between the groups. Patients with bedside IDSC, compared to telephone IDSC or lack of IDSC, had transthoracic echocardiography more often performed (odds ratio [OR] 4.00; 95% confidence interval [CI] 1.31–12.2; p = 0.012) and (OR 16.0; 95% CI, 4.00–63.9; P<0.001). Bedside IDSC was associated with more deep infections diagnosed compared to telephone IDSC (OR, 7.44; 95% CI, 2.58–21.4; p<0.001) or lack of IDSC (OR, 9.56; 95% CI, 2.43–37.7; p = 0.001). The overall mortality was 7%, 10% and 17% at 28 days, 90 days and 1 year, respectively. Considering all prognostic parameters, patients with IDSC, compared to lack of IDSC, had lower 90 days and 1 year mortality (OR, 0.11; 95% CI, 0.02–0.51; p = 0.005) and (OR, 0.22; 95% CI, 0.07–0.67; p = 0.007). CONCLUSION: IDSC may improve management and outcome of Staphylococcus lugdunensis bacteremia. Public Library of Science 2021-10-12 /pmc/articles/PMC8509883/ /pubmed/34637480 http://dx.doi.org/10.1371/journal.pone.0258511 Text en © 2021 Forsblom et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Forsblom, Erik
Högnäs, Emma
Syrjänen, Jaana
Järvinen, Asko
Infectious diseases specialist consultation in Staphylococcus lugdunensis bacteremia
title Infectious diseases specialist consultation in Staphylococcus lugdunensis bacteremia
title_full Infectious diseases specialist consultation in Staphylococcus lugdunensis bacteremia
title_fullStr Infectious diseases specialist consultation in Staphylococcus lugdunensis bacteremia
title_full_unstemmed Infectious diseases specialist consultation in Staphylococcus lugdunensis bacteremia
title_short Infectious diseases specialist consultation in Staphylococcus lugdunensis bacteremia
title_sort infectious diseases specialist consultation in staphylococcus lugdunensis bacteremia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509883/
https://www.ncbi.nlm.nih.gov/pubmed/34637480
http://dx.doi.org/10.1371/journal.pone.0258511
work_keys_str_mv AT forsblomerik infectiousdiseasesspecialistconsultationinstaphylococcuslugdunensisbacteremia
AT hognasemma infectiousdiseasesspecialistconsultationinstaphylococcuslugdunensisbacteremia
AT syrjanenjaana infectiousdiseasesspecialistconsultationinstaphylococcuslugdunensisbacteremia
AT jarvinenasko infectiousdiseasesspecialistconsultationinstaphylococcuslugdunensisbacteremia